The delay in taking action against a senior official facing allegations of harassing women at the workplace has left the ...

On Wednesday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.34 which represents a decrease of $-0.34 or -1.11% from the prior close of $30.68. The stock opened at $31.49 and ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

(Goldman, 11/27) Bloomberg: Hims & Hers Shares Rally As FDA Pick Marty Makary Seen As Major Ally Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the ...

Nutrafol is a leader in supplement-based hair loss treatments, offering a natural way to support healthy hair growth. Their ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

3. Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg reported Nov. 25. 4. Sesame provides compounded versions of the popular ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology ...

Looking for a solution for hair loss can feel like a huge undertaking. With the overwhelming number of brands to choose from ...